Mammoth Biosciences
Elaine Sun is a seasoned professional in the biopharmaceutical industry with a strong background in finance and strategic advisory. Elaine currently holds leadership positions at Asher Biotherapeutics, Mammoth Biosciences, and Dynavax Technologies. With a solid educational background from Harvard Business School and Wellesley College, Elaine has showcased their expertise as a Board Member, COO, CFO, and Strategic Advisory Consultant in various reputable companies.
This person is not in any offices
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.